Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2019 16:06 ET | Source: Codexis, Inc.

Codexis Reports First Quarter 2019 Financial Results

Total revenues increase 11% to $15.6 million, product revenue up 30% Recent highlights include Third CodeEvolver® Platform Technology Agreement and Multi-Year Enzyme Supply and Licensing Agreement...
April 30, 2019 07:00 ET | Source: Codexis, Inc.

Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of TASTEVA® M Stevia Sweetener

REDWOOD CITY, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the signing of a multi-year agreement with Tate & Lyle, a...
April 29, 2019 07:00 ET | Source: Codexis, Inc.

Codexis to Hold First Quarter 2019 Conference Call on May 6

REDWOOD CITY, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2019 financial results after...
April 05, 2019 16:05 ET | Source: Codexis, Inc.

Codexis Senior Vice President of R&D Dr. Jim Lalonde Announces Plan to Resign

REDWOOD CITY, Calif., April 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that Jim Lalonde, Ph.D., Senior Vice President of Research and...
March 05, 2019 07:00 ET | Source: Codexis, Inc.

Codexis to Participate in Two Investment Conferences in March

REDWOOD CITY, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in two upcoming investment...
February 26, 2019 16:05 ET | Source: Codexis, Inc.

Codexis Reports 2018 Fourth Quarter and Full Year Financial Results

2018 revenues of $61 million include a 50% increase in R&D revenue Introduces 2019 financial guidance Conference call begins at 4:30 pm Eastern time todayAccompanying slide presentation available...
February 25, 2019 07:00 ET | Source: Codexis, Inc.

Codexis Names Laurie Heilmann Senior Vice President of Business Development and Marketing

REDWOOD CITY, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the appointment of Laurie Heilmann to Senior Vice President of...
February 19, 2019 07:00 ET | Source: Codexis, Inc.

Codexis to Hold 2018 Fourth Quarter and Full Year Conference Call on February 26

REDWOOD CITY, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report 2018 fourth quarter and full year financial...
February 14, 2019 07:00 ET | Source: Codexis, Inc.

Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria

REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that Nestlé Health Science has exercised its option to obtain...
February 06, 2019 07:00 ET | Source: Codexis, Inc.

Codexis Announces Enzyme Supply Agreement with KYORIN Pharmaceutical for Overactive Bladder Drug Sold in Japan

REDWOOD CITY, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) announces a multi-year, exclusive supply agreement with KYORIN Pharmaceutical Co., Ltd. for the supply of a...